Loading...
Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set
van Balen, Erna C. O'Mahony, Brian Cnossen, Marjon H. Dolan, Gerard Blanchette, Victor S. Fischer, Kathelijn Gue, Deborah O'Hara, Jamie Iorio, Alfonso Jackson, Shannon
van Balen, Erna C.
O'Mahony, Brian
Cnossen, Marjon H.
Dolan, Gerard
Blanchette, Victor S.
Fischer, Kathelijn
Gue, Deborah
O'Hara, Jamie
Iorio, Alfonso
Jackson, Shannon
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2021-03-06
Submitted Date
Collections
Files
Loading...
Article - VoR
Adobe PDF, 923.52 KB
Other Titles
Abstract
Background: Patient‐relevant health outcomes for persons with hemophilia should be identified and prioritized to optimize and individualize care for persons with hemophilia. Therefore, an international group of persons with hemophilia and multidisciplinary health care providers set out to identify a globally applicable standard set of health outcomes relevant to all individuals with hemophilia. Methods: A systematic literature search was performed to identify possible health outcomes and risk adjustment variables. Persons with hemophilia and multidisciplinary health care providers were involved in an iterative nominal consensus process to select the most important health outcomes and risk adjustment variables for persons with hemophilia. Recommendations were made for outcome measurement instruments. Results: Persons with hemophilia were defined as all men and women with an X‐linked inherited bleeding disorder caused by a deficiency of coagulation factor VIII or IX with plasma activity levels <40 IU/dL. We recommend collecting the following 10 health outcomes at least annually, if applicable: (i) cure, (ii) impact of disease on life expectancy, (iii) ability to engage in normal daily activities, (iv) severe bleeding episodes, (v) number of days lost from school or work, (vi) chronic pain, (vii) disease and treatment complications, (viii) sustainability of physical functioning, (ix) social functioning, and (x) mental health. Validated clinical as well as patient‐reported outcome measurement instruments were endorsed. Demographic factors, baseline clinical factors, and treatment factors were identified as risk‐adjustment variables. Conclusion: A consensus‐based international set of health outcomes relevant to all persons with hemophilia, and corresponding measurement instruments, was identified for use in clinical care to facilitate harmonized longitudinal monitoring and comparison of outcomes.
Citation
van Balen, E. C., O'Mahony, B., Cnossen, M. H., Dolan, G., Blanchette, V. S., Fischer, K., Gue, D., O'Hara, J., Iorio, A., Jackson, S., Konkle, B. A., Nugent, D. J., Coffin, D., Skinner, M. W., Smit, C., Srivastava, A., van Eenennaam, F., van der Bom, J. G., & Gouw, S. C. (2021). Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set. Research and Practice in Thrombosis and Haemostasis, 5(4), article-number e12488. https://doi.org/10.1002/rth2.12488
Publisher
Elsevier
Journal
Research and Practice in Thrombosis and Haemostasis
Research Unit
DOI
10.1002/rth2.12488
PubMed ID
PubMed Central ID
Type
Article
Language
Description
© 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis
Series/Report no.
ISSN
EISSN
2475-0379